⚠️Educational purposes only. Not medical advice. Consult a licensed provider before use. Many peptides are research-grade compounds not FDA-approved. Verify legal status in your jurisdiction.
← Back to library
Humanin
Humanin (HN)
PreclinicalResearch Grade
A mitochondria-derived peptide with cytoprotective properties — emerging evidence supports roles in neuroprotection, insulin sensitivity, and cardiovascular health.
Mechanism of action
Mitochondrial cytoprotection, STAT3 signaling, apoptosis inhibition, IGF-1 pathway modulation
Primary benefits
- ✓Neuroprotection
- ✓Insulin sensitivity
- ✓Cardiovascular protection
- ✓Anti-apoptotic
- ✓Longevity signaling
Dosing
Beginner
1-2 mg 2-3x weekly
Intermediate
2-4 mg 2-3x weekly
Advanced
4 mg 3x weekly
Frequency: 2-3x per week
Timing: Any time of day
Route: Subcutaneous injection
Cycling protocol
Duration
8-12 weeks
Pattern
3x weekly
Break after
4-6 weeks
Important warnings
- ⚠️Very limited human data
- ⚠️Emerging research only
- ⚠️Use with caution